THE STAPHYLOCOCCUS AUREUS NETWORK ADAPTIVE PLATFORM TRIAL
Grant number: 1184238 | Funding period: 2020 - 2024
Active
Abstract
There are an estimated 5000 episodes per year of bloodstream infections due to Staphylococcus aureus (golden staph) in Australia and an associated mortality of 20%. Despite this, there is little clinical trials evidence to guide best management. The Staphylococcus aureus Network Adaptive Platform trial (SNAP) will be a novel, large scale, international clinical trial that will both establish best practice evidence and optimise care for patients during the conduct of the trial.